EUVIMEDEUVIMED entdecken
Crossref

Advancing Bariatric Strategies: Different Gastric Balloons in 2454 Patients

Christophe Bastid, Thierry Manos, Jonathan Bastid, Caroline Bastid, Marius Nedelcu iD, Anamaria Nedelcu

Journal of Laparoendoscopic & Advanced Surgical Techniques · 2026

DOI: 10.1177/10926429251411136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Laparoendoscopic & Advanced Surgical Techniques, 2026. Verfasst von Christophe Bastid und 5 weiteren Autor:innen. Beteiligte Einrichtung: ELSAN, Clinique Bouchard, Marseille, France. Hauptthemen laut MEDLINE: Gastric Balloon, Obesity, Morbid, Bariatric Surgery. Die Arbeit nennt 22 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intragastric balloons (IGB) have been used for more than 40 years to reduce weight in overweight and obese patients. The purpose of the current study will be to evaluate our case series regarding different types of IGB.

Methods

A total of 2454 patients who underwent IGB placement between 2002 and2022 were included in a retrospective single-center study. There were used in the majority of cases 3 types of IGB. The primary outcome of the current study was the evaluation of weight loss results at 6 and 12 months after IGB. The secondary outcome was the evaluation of the results between different approaches for the IGB placement: by endoscopy versus balloon placed without endoscopy; with adjuvant therapy (e.g., hypnosis) versus without.

Results

Various intragastric devices were employed, including the Orbera® intragastric balloon for 6 months in 1290 cases (52.6%), Orbera 365® in 614 cases (25.1%), the Allurion® intragastric balloon in 508 cases (20.7%), and other devices in 42 cases (1.7%). We have recorded 22 cases (0.89%) with different types of complications as follows: 14 cases (63.6%) severe hypokalemia requiring hospitalization; 4 cases (18. %) of spontaneous balloon deflation; 2 patients (9.1%) who necessitated a laparoscopic surgery; 1 case (4.5%) of hyperinflation; 1 case (4.5%) of Mendelson syndrome. The percentage total body weight loss was 12.1% ± 5.2%. There were no major intra-procedure adverse events and no mortality recorded.

Conclusions

Recent advancements, such as the integration of robust multidisciplinary support—especially hypnotherapy—and the systematic application of ultrasound to reduce premature withdrawals, require validation through multicentric studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastric BalloonObesity, MorbidBariatric SurgeryHumansRetrospective StudiesFemaleWeight LossAdultMaleMiddle AgedTreatment Outcome

Stichwörter der Autor:innen

AllurionOrberacomplicationintragastric balloonobesity

Autor:innen und Institutionen

  • ELSAN, Clinique Bouchard, Marseille, France.
  • Department of gastroenterology, Hopitaux Universitaire de Geneve, Geneva, Switzerland.
  • Department of digestive surgery, Hopital Archet, University Hospital of Nice, France.

ORCID-Profile: Marius Nedelcu

Zitieren

APA

Bastid, C., Manos, T., Bastid, J., Bastid, C., Nedelcu, M., & Nedelcu, A. (2026). Advancing Bariatric Strategies: Different Gastric Balloons in 2454 Patients. Journal of Laparoendoscopic & Advanced Surgical Techniques. https://doi.org/10.1177/10926429251411136

Vancouver

Bastid C, Manos T, Bastid J, Bastid C, Nedelcu M, Nedelcu A. Advancing Bariatric Strategies: Different Gastric Balloons in 2454 Patients. Journal of Laparoendoscopic & Advanced Surgical Techniques. 2026. doi:10.1177/10926429251411136

BibTeX
@article{Bastid2026,
  author = {Bastid, Christophe and Manos, Thierry and Bastid, Jonathan and Bastid, Caroline and Nedelcu, Marius and Nedelcu, Anamaria},
  title = {Advancing Bariatric Strategies: Different Gastric Balloons in 2454 Patients},
  journal = {Journal of Laparoendoscopic & Advanced Surgical Techniques},
  year = {2026},
  doi = {10.1177/10926429251411136}
}
Kostenlos starten →